Why the study?
Infection with live-attenuated vaccines inevitably induces side effects that reduce their safety.
Does magnetic modification of EV71 with Fe3O4 nanoparticles allow for targeted infection and reduced pathological damage in vitro and in vivo?
Does magnetic modification of EV71 with Fe3O4 nanoparticles allow for targeted infection and reduced pathological damage in vitro and in vivo?
Answers are grounded in this paper and cite their sources.
Genetically modifying EV71 with Fe3O4 nanoparticles allows for magnetic control of viral tropism, offering a proof of concept for improving live-attenuated vaccine safety.
Infection with live‐attenuated vaccines always inevitably induces side effects that reduce their safety. This study suggests a concept of magnetic virus produced by genetically modifying viral surfaces with Fe 3 O 4 nanoparticles (NPs) to control their tropisms. An iron‐affinity peptide is designed to be displayed on the viral surface protein (VP1) of human enterovirus type 71 (EV71), a typical nonenveloped picornavirus, as the model. The modified EV71 can self‐bind with Fe 3 O 4 NPs under physiological conditions, resulting in novel EV71‐Fe 3 O 4 hybrid materials. This rationally engineered EV71 with Fe 3 O 4 retains its original biological infectivity, but its tropism can be precisely controlled by magnetism. Both in vitro and in vivo experiments demonstrate that EV71‐Fe 3 O 4 can infect only a desired area within the limit of the applied magnetic field, which effectively reduces its pathological damage. More importantly, this characteristic of EV71 can be inherited due to the gene‐induced coassembly of viruses and NPs. This achievement provides a proof of concept in virus vaccine improvement by a combination of gene modification and material incorporation, leading to great potential for biomedical developments.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: